Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women. The analysis, published in...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2Hmp5A3
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου